title: Pharmacokinetic monitoring of antiepileptic drugs.
abstract: Monitoring plasma levels of antiepileptic drugs for the treatment and prophylaxis of epilepsy is one of the strategies enabling clinical results to improve by reducing adverse affects and increasing effectiveness. The objective of this article is to review the basic aspects in the monitoring of antiepileptic drugs using a consensus document prepared and endorsed by the pharmacokinetics and pharmacogenetics working group (PK.gen) of the Sociedad Española de Farmacia Hospitalaria (Spanish Society of Hospital Pharmacists).
authors.affiliation: Servicio de Farmacia, Clínica Universitaria, Pamplona, España.
authors.forename: A
authors.initials: A
authors.lastname: Aldaz
authors.forename: R
authors.initials: R
authors.lastname: Ferriols
authors.forename: D
authors.initials: D
authors.lastname: Aumente
authors.forename: M V
authors.initials: MV
authors.lastname: Calvo
authors.forename: M R
authors.initials: MR
authors.lastname: Farre
authors.forename: B
authors.initials: B
authors.lastname: García
authors.forename: R
authors.initials: R
authors.lastname: Marqués
authors.forename: P
authors.initials: P
authors.lastname: Mas
authors.forename: B
authors.initials: B
authors.lastname: Porta
authors.forename: M
authors.initials: M
authors.lastname: Outeda
authors.forename: D
authors.initials: D
authors.lastname: Soy
mesh_terms: D000927:Anticonvulsants / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D003245:Consensus Statements as Topic; D016903:Drug Monitoring / Q000592:standards*; D004827:Epilepsy / Q000097:blood / Q000188:drug therapy*; D006801:Humans
chemical_list: D000927:Anticonvulsants